arrow
R

Roland G. Henry

University of California San Francisco
H指数:73
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2024 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis

2024年MAGNIMS–CMSC–NAIMS关于MRI在多发性硬化症诊断中应用的共识建议

2025-09-170
PRE
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis

HLA-A∗03:01作为预测干扰素β治疗反应的遗传生物标志物在多发性硬化中的研究:一项回顾性队列分析

2025-07-310
PRE
High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis

大剂量脉冲糖皮质激素治疗可预防新诊断多发性硬化患者脊髓白质的假性萎缩

2025-06-240
OAAI
The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
2024-10-090
OA
Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis

多中心自动化中心静脉征检测在多发性硬化症诊断中的表现与手动评估相当

2024-09-271
PRE
Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis

多发性硬化症的中心静脉征与寡克隆带的诊断性能

2024-09-050
PRE
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis

炎性和神经退行性血清蛋白生物标志物可提高对多发性硬化症临床及影像学疾病活动性的检测灵敏度。

2024-05-202
OAAI
Imaging chronic active lesions in multiple sclerosis: a consensus statement

多发性硬化症的慢性活动性病变成像: 共识声明

BRAIN
IF11.7
2024-01-1629
OA
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis

评估简化中央静脉评估以诊断多发性硬化症的多中心初步研究

2023-12-138
OA
Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease

基于敏感性的成像有助于准确区分儿科发作的MS与髓磷脂少突胶质细胞糖蛋白抗体相关疾病

2023-10-2810
OAAI